Table 3 Relationship between CAP, LSM, MASLD status and CDAI in a multiple regression model.

From: RETRACTED ARTICLE: Association between the composite dietary antioxidant index and metabolic dysfunction-associated steatotic liver disease in adults: a cross-sectional study from NHANES 2017–2020

Outcome

Crude model

Model I

Model II

 

Beta (95% CI)

Beta (95% CI)

Beta (95% CI)

CDAI (CAP)

 − 0.572 (− 1.120, − 0.025)

 − 0.779 (− 1.269, − 0.289)

 − 0.497 (− 0.833, − 0.160)

 Q1

Ref

Ref

Ref

 Q2

3.044 (− 2.859, 8.946)

 − 0.132 (− 5.653, 5.390)

0.2 (− 2.154, 2.554)

 Q3

2.304 (− 3.113, 7.721)

 − 1.283 (− 6.195, 3.628)

 − 2.431 (− 5.699, 0.836)

 Q4

 − 2.25 (− 8.901, 4.401)

 − 5.3 (− 11.606, 1.006)

 − 3.574 (− 7.243, 0.095)

 p for trend

0.257

0.042

0.038

 

Beta (95% CI)

Beta (95% CI)

Beta (95% CI)

CDAI (LSM)

0.031 (− 0.011, 0.074)

0.027 (− 0.017, 0.071)

0.046 (0.007, 0.085)

 Q1

Ref

Ref

Ref

 Q2

 − 0.438 (− 0.780, − 0.096)

 − 0.518 (− 0.883, − 0.152)

 − 0.44 (− 0.880, 0.001)

 Q3

 − 0.312 (− 0.675, 0.051)

 − 0.408 (− 0.776, − 0.041)

 − 0.36 (− 0.825, 0.106)

 Q4

0.039 (− 0.385, 0.463)

 − 0.021 (− 0.465, 0.424)

0.147 (− 0.275, 0.569)

 p for trend

0.345

0.484

0.083

 

OR (95% CI)

OR (95% CI)

OR (95% CI)

CDAI (MASLD)

0.984 (0.967, 1.001)

0.976 (0.960, 0.993)

0.981 (0.961, 1.002)

 Q1

Ref

Ref

Ref

 Q2

1.127 (0.912, 1.392)

1.034 (0.834, 1.280)

1.062 (0.833, 1.353)

 Q3

1.130 (0.920, 1.387)

1.033 (0.846, 1.262)

0.954 (0.747, 1.217)

 Q4

0.969 (0.769, 1.222)

0.879 (0.695, 1.110)

0.918 (0.700, 1.203)

 p for trend

0.518

0.156

0.349

  1. Crude Model: without adjusting for any covariates. Model I: adjusted for age, gender, and ethnicity. Model II: adjusted for the variables of age, gender, ethnicity, marital status, education level, diabetes mellitus, hypertension, PIR, waist circumference, BMI, smoking, and alcohol use.
  2. MASLD Metabolic dysfunction-associated steatotic liver disease, CDAI composite dietary antioxidant index, Q quartile, CAP controlled attenuation parameter, LSM liver stiffness measurement, PIR family income-to-poverty ratio, BMI body mass index, CI confidence intervals.